1. Inicio
  2. Acciones
  3. Reino Unido
  4. London Stock Exchange
  5. Renalytix Plc
  6. Noticias
  7. Otros idiomas
    RENX   GB00BYWL4Y04

RENALYTIX PLC

(RENX)
  Reporte
Diferido London Stock Exchange  -  17:35 05/08/2022
102.50 GBX    0.00%
01/07RENALYTIX PLC : El BTIG continua con un recomendación de compra
MM
01/07RENALYTIX PLC : Stifel Nicolaus mantiene su recomendación de compra
MM
01/07RENALYTIX PLC : Recibe una recomendación de compra del HC Wainwright
MM
ResumenCotizacionesGráficosNoticiasRatingsAgendaEmpresaFinanzasConsensoRevisionesDerivados 
ResumenTodasRecomendaciones analistasOtros idiomasComunicadosPubls. oficialesNoticias del sector
Noticias en otros idiomas sobre RENALYTIX PLC
30/06POINT SUR LES FORTES VARIATIONS DU J : Metabolic Explorer se fait étrillé
30/06TRANSCRIPT : Renalytix Plc, Q3 2022 Earnings Call, Jun 30, 2022
30/06RENALYTIX : Reports Financial Results for Third Quarter of Fiscal Year 2022 - Form 6-K
30/06Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022
30/06Earnings Flash (RNLX) RENALYTIX Posts Q3 Revenue $812,000
30/06Renalytix Plc Reports Earnings Results for the Third Quarter and Nine Months Ended Marc..
23/06Renalytix to Report Financial Results for Third Quarter Fiscal 2022 on June 30
10/06Renalytix Says Diabetic Kidney Disease Tool Showed Benefits in Real-World Study
10/06Renalytix Plc Announces 1,112 Patient Study Demonstrates Clinical Utility and Care Bene..
10/06Renalytix's Kidney Disease Testing Tool Shows Clinical Utility in US Trial
06/06Renalytix Says Test Shows Ability to Assess Heart Failure Hospitalization, Death Risks ..
06/06KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalizatio..
06/06Renalytix Says Platform Can Assess Risk of Heart Failure Hospitalization in Diabetic Ki..
06/06Renalytix plc Announces That Kidneyintelxtm Successfully Risk-Stratified Adult Patients..
06/06Renalytix Helds Two Data Presentations on Kidneyintelx at American Diabetes Association..
02/06Renalytix Announces Two Data Presentations on KidneyIntelX™ at American Diabetes ..
08/04Renalytix plc successful completion of $30.0 million financing package
08/04Renalytix Raises $30 Million in Equity, Debt Financing
08/04Renalytix Plc announced that it has received $18.02 million in funding from Heights Cap..
01/04RENALYTIX : THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET A..
31/03Earnings Flash (RNLX) RENALYTIX Reports Q2 Revenue $845,000
31/03Renalytix to Raise Nearly $27 Million in Equity, Debt Financing
31/03TRANSCRIPT : Renalytix Plc, Q2 2022 Earnings Call, Mar 31, 2022
31/03RENALYTIX : Reports Financial Results for Second Quarter of Fiscal Year 2022 - Form 6-K
31/03Renalytix AI Up 19% After Pricing Fundraise
31/03FTSE Rises as Traders Continue to Monitor Ukraine Crisis
31/03RENALYTIX : FY22 Half Year Results (December, 2021)
31/03Earnings Flash (RENX.L) RENALYTIX Reports Fiscal H1 Revenue $1.3M
31/03Earnings Flash (RENX.L) RENALYTIX Posts Fiscal H1 Loss $-0.32
31/03Renalytix Plc Reports Earnings Results for the Half Year Ended December 31, 2021
31/03Renalytix Plc announced that it expects to receive $18.02 million in funding from Heigh..
30/03Renalytix plc Appoints Timothy Scannell as Independent Non-Executive Director
29/03Renalytix Reaches Enrollment Milestone for Building KidneyIntelX as Premier Precision M..
29/03Renalytix plc Reaches Enrollment Milestone for Building Kidneyintelx as Premier Precisi..
09/03Renalytix Launches myIntelX, Providing National Physician Access to KidneyIntelX Testin..
09/03Renalytix plc Announces the Launch of Its New Provider Access Portal, myIntelX
24/02KidneyIntelX™ Clinical Results Presented at World Congress of Nephrology Demonstr..
24/02Renalytix plc Announces the Presentation of New Clinical Data for KidneyIntelX Bioprogn..
22/02Renalytix to Appoint Timothy Scannell to Board of Directors
22/02Renalytix Plc to Appoint Timothy Scannell to Board of Directors
07/02Renalytix Shares Decline to Joint Lowest Level in 52 Weeks
27/01RENALYTIX : Amendment to Annual Report by Foreign Issuer (Form 20-F/A)
27/01Renalytix to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools C..
12/01TRANSCRIPT : Renalytix Plc Presents at JPMorgan 40th Annual Healthcare Conference, Jan-12-..
11/01Positive Study Results Published for KidneyIntelX™ in Monitoring Patient Response..
11/01Renalytix Announces Positive Study Results Published for KidneyIntelX™ in Monitori..
10/01Renalytix, Singing River Health System Partner To Improve Kidney Health
10/01Singing River Health System and Renalytix Join Forces to Improve Kidney Health on the M..
10/01Singing River Health System and Renalytix Join Forces to Improve Kidney Health on the M..
07/01Renalytix Appoints Successor For Outgoing Chief Human Resources Officer
07/01Renalytix plc Appoints Jean M. Casner as Senior Vice President & Chief Human Resources ..
05/01Renalytix to Present at 40th Annual J.P. Morgan Virtual Healthcare Conference
04/01Renalytix Working With American Diabetes Association to Develop Kidney Health Program f..
04/01American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type..
04/01Renalytix Joins Program To Improve Kidney Health Of Diabetes Patients In US
04/01American Diabetes Association and Renalytix plc Announce Joint Program to Improve Overa..
2021RENALYTIX : Reports Financial Results for First Quarter of Fiscal Year 2022 - Form 6-K
2021Renalytix Posts Wider Fiscal Q1 Loss
2021Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
2021Renalytix Plc Reports Earnings Results for the First Quarter Ended September 30, 2021
2021RENALYTIX : Notice of AGM 2021
2021RENALYTIX : Notification Letter – November 2021
2021RENALYTIX : FY21 Annual Report and Financial Statements
2021Renalytix Convenes Expert Panel at VA Healthcare Summit
2021St. Joseph's Health and Renalytix Partner to Advance Value-Based Kidney Health in New Y..
2021St. Joseph's Health and Renalytix plc Announces Partnership
2021Health Care Stocks Steady Pre-Bell Thursday
2021RENALYTIX : Annual Report by Foreign Issuer (Form 20-F)
2021RENALYTIX : Reports Wider Full-Year Fiscal 2021 Loss
2021RENALYTIX : Reports Full Year Fiscal 2021 Results
2021RENALYTIX : Reports Full Year Fiscal 2021 Results - Form 6-K
2021RENALYTIX : Earnings Flash (RENX.L) RENALYTIX Posts FY21 Loss $-0.43
2021RENALYTIX : Earnings Flash (RENX.L) RENALYTIX Reports FY21 Revenue $1.5M
2021Renalytix Plc Reports Earnings Results for the Full Year Ended June 30, 2021
2021Renalytix to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results on Octob..
1  2  3Siguiente